|NAME :||BICHAY, Tewfik Jermyn|
|CITIZENSHIP :Canadian||U.S. STATUS: Permanent Resident|
|BUSINESS ADDRESS||HOME ADDRESS|
|Director, Medical Physics||6222 13 Mile Road,|
|Radiation Oncology||Rockford, MI., 49341|
|The Lacks Cancer Center||p. 616-863-8664|
|St. Mary's Health Care,||c. 616-485-7602|
|200 Jefferson S. E. Grand Rapids MI., 49503 p. 616-685-6367 616-685-6218 (secretary)|
|LANGUAGES ACADEMIC EDUCATION||Spoken: French, English Written: French, English|
|Ph.D. 1987.||MEDICAL BIOPHYSICS, University of Western Ontario, London, Canada.|
|M.Sc. 1983.||(RADIATION) BIOLOGY, Concordia University, Montreal, Canada.|
|B.Sc. 1978.||(HUMAN) PHYSIOLOGY, McGill University,|
SPECIALIZED TRAINING AND CERTIFICATION
May 1997 Certified in Radiation Oncology Physics by the AMERICAN BOARD OF MEDICAL PHYSICS.
October 15,1992 Ontario CERTIFICATION IN MEDICAL PHYSICS PEER REVIEW "A".
September, 1993 PHYSICS OF MAMMOGRAPHY, Sunnybrook Hospital, Toronto, Canada
February 1991-October 1992 MEDICAL PHYSICS RESIDENCY PROGRAM at the Ottawa Regional Cancer Center, Ottawa, Canada.
1987 (Sept-Oct) Intensive course in RADIATION PROTECTION at Atomic
Energy of Canada Ltd., Chalk River, Ontario.
March 1996- Director of Medical Physics, Radiation Oncology, The Lacks Cancer Center at St. Mary's Health Care. Duties include all aspects of Radiation Oncology Physics. Special emphasis on TomoTherapy physics and treatment planning.
Significant emphasis of this position is to search for, negotiate and implement state-of-theart technologies. Recent examples include TomoTherapy, Cone beam CT, respiratory gating, radiosurgery, etc. This position also includes treatment planning, physics support for simulation, treatment setups, treatment and simulator unit quality assurance, chart checks, and all NRC and state related issues. Current position also includes administrative leadership and supervision of physics and dosimetry staff in the department of Radiation Oncology.
July 2015-August 2017 Radiation Safety Officer, Mercy Health Grand Rapids.
March 1996-Sep 2005 Department manager, in addition to medical physics responsibilities stated above. Responsible for all aspects of radiation oncology program including budgets, all department personnel including nursing, radiation therapists, front desk, medical physicists, and medical dosimetrists.
1994-1996. Chief Radiation Oncology Physicist and Radiation Safety Officer, Department of Radiation Oncology, Hurley Medical Centre, Flint, MI, 48503. Duties included all aspects of medical physics as well as supervision of medical physics and dosimetry.
1992-1994 Medical Physicist, Department of Medical Physics, Ottawa Regional Cancer Center (ORCC), 190 Melrose Ave., Ottawa, Ontario, Canada K1Y 4K7. Responsibilities included the supervising of the technical operation of the Dosimetry Department with special emphasis in the area of treatment planning. Duties included all aspects of Medical Physics including quality assurance for orthovoltage, cobalt and high energy linear accelerators, competence in treatment planning for all cancer sites, as well as involvement in numerous developmental and research projects especially total-body-irradiation, thermoluminescent dosimetry (TLD) for orthovoltage treatment and numerous radiobiological studies.
1991-1992 Medical physics resident, ORCC, Supervisors were department head Dr. G. Peter Raaphorst (radiobiology) and Dr. Janos Szanto (medical physics).
1989-1991 Research Fellow, Medical Biophysics Laboratory, Ontario Cancer
Treatment and Research Foundation. Research in radiobiology carried out under Dr. Peter G. Raaphorst. The research area involves projects to study the radiobiology of established human melanoma cell lines with special emphasis on recovery from radiation damage and the role of and polymerase enzymes in radiosensitivity when combined with hyperthermia treatment. The cells are studied under conditions of high density monolayers and as three-dimensional multicell spheroids.
1987-1989 Research Fellow, Radiation Biology Branch, Division of Physics and
Health Sciences, Atomic Energy of Canada Research Company Ltd., Chalk River Nuclear Laboratories. Worked on a major project involving screening healthy individuals and cancer patients for abnormal radiosensitivity. Developed an assay for measuring the response of stimulated peripheral blood lymphocytes to ionizing radiation. Also worked with Dr. RE Mitchel on mechanisms of carcinogenesis using the In Vivo model C3H10T1/2 cell transformation assay.
1986-1987 Research Biologist (While pursuing PhD studies), Department of Cancer and Viral Diseases Research, The Upjohn Company, Kalamazoo, Michigan, U.S.A. Carried out research related to my Ph.D. studies in the laboratories of Drs. BK Bhuyan and LH Li on the uptake and toxicity of anthracyclines in multicell spheroids. Established the first industrial spheroid laboratory to be used as part of the drug development and testing program at Upjohn.
1982-1983 Research Assistant (while pursuing M.Sc. studies), Concordia University, Department of Biology, Montreal, Canada. Worked with Dr. RM Roy on the modification of radiosensitivity of CD-1 mice by a-tocopherol treatment. The project included studies of animal survival, micronuclei induction, as well as survival of irradiated, endogenous and transplanted, bone marrow cells in immunodefficient recipients.
1978-1979 Research Technician, Concordia University, Department of Biology.
Worked in laboratory of Dr. RM Roy on the uptake and distribution of various radioisotopes in mice and rats.
2006- Associate professor (adjunct), Radiation Oncology, Wayne State University School of Medicine, Detroit, Michigan.
2003- Adjunct professor, Imaging Sciences, Grand Valley State University, Grand Rapids, Michigan.
1991-1995. Assistant professor, Department of Radiology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
1984-1986. Teaching assistant, Department of Medical Biophysics, University of Western Ontario, London, Ontario, Canada.
1979-1982. Teaching assistant, Concordia University, Department of Biology, Montreal, Quebec, Canada.
OTHER RELATED EXPERIENCE
2017- Editorial board member: Clinical Neurosurgery Research
2017- Editorial board member: Annals of Radiation Therapy and Oncology
2016- Associate editor: Journal of Radiology and Oncology
2016- Editorial board member: Clinics in Oncology, Chemotherapy and Radiotherapy
2011- Physicist accreditation surveyor: American College of Radiology,
2009-2016 MOC Medical Physics committee: American Board of Radiology,
2009-2011 President: Greal Lakes Chapter of the American Association of Medical Physicists (GLC-AAPM)
2003-2005 Radiation Safety Officer: School of Imaging Sciences, Grand Valley State University
1988-1989 Chairman: Deep River Science Association, Deep River, Ontario, Canada
1985-1987 Radiation Safety Officer: Experimental Oncology Group, London Regional Cancer Center, London, Ontario
AWARDS AND PATENTS
2007-2012. Patents issued for the design of a compact doorless high energy vault (US Patent 7291854, 7728315, 8101932).
- International Congress of Radiation Research Young Investigator Travel Award (Toronto).
- Radiation Research Society Young InvestigatorTravel Award (New Orleans). 1989. Radiation Research Society Young InvestigatorTravel Award (Seattle).
1987-1989. Atomic Energy of Canada (AECL) Research Fellowship.
1983-1986. University of Western Ontario Graduate Scholarship.
- Cyanamid Pharmaceutical Co. (Canada) Travel Award (Houston, TX.). 1979-1981. Concordia Graduate Teaching Fellowship.
Expert member for Standards Advisory Commission, State of Michigan Certificate of Need Commission, 2014-2015.
American Association of Physicists in Medicine (AAPM).
AAPM member of Task Group (BE08) on Volumetric Tissue Response Models in Radiation Therapy.
AAPM (AA) African Affairs Subcommittee.
AAPM (MEA) Middle East Affairs Subcommittee.
AAPM (ESPS) Exchange Scientist Program Subcommitee.
AAPM Great Lakes Chapter. (President 2009-2011 )
Chairman, Radiation Therapy Professional Advisory Committee (Grand Valley State University 2004-2006).
Grand Valley State University School of Health Professions Advisory Committee 2003- State of Michigan MRT Special Advisory Committee (2004-2005)
SELECTED RECENT LECTURES
June 14, 2017. Assessment of Cranial Motion in Thermoplastic Masks During CyberKnife Radiosurgery. AAMD Symposium, June 11-15, 2017, Indianapolis, IN.
April 8, 2017. A Quantitative Assessment of Imaging Frequency on the Treatment Setup Accuracy in TomoTherapy®. AERO Summit 2017, April 7-8, 2017, Chicago, IL.
October 20, 2015. Clinical Experience with Incise™: A New CyberKnife® Multileaf Collimator. ASTRO 2015 Industry Expert Theater Symposium, Oct 18-21, 2015, San Antonio, TX.
June 11, 2015. Treatment Plan Quality, Treatment Time Efficiency and Dosimetric Accuracy of a New CyberKnife Multileaf Collimator. The International Society for Radio Surgery Conference June 7-11, 2015,Yokohama, Japan.
May 7, 2014. The Use of TomoTherapy for the Treatment of Trigeminal Neuralgia. 2014 Accuray / AERO users meeting:Frontiers of Image-Guidance. May 6-7, 2014. Minneapolis, MN.
May 29, 2013. Safety in Radiation Oncology I: An Overview of Recent Errors, & A Guide to Future Behavior. Grand Rapids, MI.
May 29, 2013. Safety in Radiation Oncology II: An Overview of Recent Errors, & A Guide to Future Behavior. Grand Rapids, MI.
May 29, 2012. Tomotherapy Radiosurgery For Trigeminal Neuralgia: A Technical Perspective. World Congress on Medical Physics and Boimedical Engineering, May 26-31, 2012, Beijing, China.
May 30, 2012. A Quantitative Analysis of the Reliability of Aquaplast Mask Immobilization for Cranial Radiosurgery With TomoTherapy. World Congress on Medical Physics and Boimedical Engineering, May 2631, 2012, Beijing, China.
Sep 17, 2010. AccuBoost: Mammography for Image-Guided Radiation Therapy. Presented at the 54th Annual Meeting of the Michigan Society of Radiologic Technologists. September 14-17, 2010, Bay City, Michigan.
May 14, 2010. AccuBoost: Mammography for Image-Guided Radiation Therapy. Breast Imaging 2010-Current Issues in the Diagnoses of Breast Cancer. May 14, 2010, Grand Rapids, MI.
October 8, 2009. From Photons to Electrons to Protons: The Negatives, the Positives and the Neutrals. Annual meeting of the Michigan Society of Radiologic Technologists. October 7-9, 2009, Bay City, MI.
May 5, 2009. TomoTherapy for Cranial Tumors: Saint Mary’s Experience. Karmanos Cancer Institute, Wayne State University, Detroit, MI.
Sep 19, 2008. TomoTherapy: an Overview. Presented at the 52nd Annual Meeting of the Michigan Society of Radiologic Technologists. September 17-19, 2008, Midland, MI.
July 28, 2008. TomoTherapy SRS for Cranial Tumors: Saint Mary's Experience. TomoTherapy booth talk at the American Association of Physicists in Medicine, July 26-31, Houston, TX.
June 14, 2008. TomoTherapy for Cranial Tumors: Saint Mary's Experience. Presentation. The fourth annual TomoTherapy conference, June 13-14, Madison, WI.
June 13, 2008. Treatment Planning Techniques for Critical Tissue Protection. Presentation and panel discussion. The fourth annual TomoTherapy conference, June 13-14, Madison, WI.
April 25, 2008. Radiosurgery with a Tomotherapy unit for the treatment of small cranial lesions. NCCAAPM Spring Conference, Mayo Clinic, Rochester, MN.
November 20, 2007. Imaging Dosimetry in TomoTherapy. Imaging dosimetry in diagnostic CT and image-guided radiotherapy symposium. Novi, MI.
July 22, 2007. TomoTherapy for Cranial Radiosurgery/Radiotherapy. TomoTherapy booth talk at the American Association of Physicists in Medicine, July 22-26, Minneapolis, MN.
June 17, 2007. Respiratory Gating with Siemens Anzai System. Radiation Oncology Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
June 17, 2007. A Doorless Radiation Bunker. Radiation Oncology Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
June 13, 2007. An Overview of TomoTherapy. Radiation Oncology Department, King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.
May 12, 2007. Michigan's First Doorless Radiation Therapy Rooms”. Great Lakes Chapter of the American Association of Physicists in Medicine, Professional/Education Symposium. May 12, 2007, Birmingham, MI.
March 16, 2007. Radiobiology: MSRT Review Course. Michigan Society of Radiologic Technologist Mid - America Conference, March 16-17, 2007, Flint, MI.
June 10, 2006. IGRT Utilizing the Hi-Art TomoTherapy System. Annual Ohio River Valley-AAPM meeting, June 10, 2006, Dayton, OH.
May 5, 2006. The Treatment of Intracranial Lesions With TomoTherapy. The Second Annual TomoTherapy IG/IMRT Meeting, May 5-6, 2006, Long Beach, CA.
March 21, 2006. The Great Debate: Will TomoTherapy Ultimately Replace Linear Accelerator-Based IMRT as the Best Way to Deliver Conformal Radiotherapy. Michigan Society of Therapeutic Radiologists and Oncologists
(MSTRO). March 21, 2006, Novi, MI.
November 12, 2005. Image Guided Radiation Therapy: Helical CT Approach (TomoTherapy). Annual Meeting of the Indiana Academy of Radiation Oncology. November 12, 2005, Indianapolis, IN.
September 14, 2005. TomoTherapy: Saint Mary’s Experience. The 50th Annual Meeting of the Michigan Society of Radiologic Technologists. September 13-15, 2005 Midland, MI.
PAPERS, THESES AND REPORTS
Christos Moustakis; Mark K.H. Chan; Jinkoo Kim; Joakim Nilsson; Alanah Bergman; Tewfik J. Bichay;
Isabel Palazon Cano; Savino Cilla; Francesco Deodato; Raffaela Doro; Juergen Dunst; Hans Theodor Eich;
Pierre Fau; Ming Fong; Uwe Haverkamp; Simon Heinze; Guido Hildebrandt; Detlef Imhoff; E.C. de Klerck;
Janett Koehn; Ulrike Lambrecht; Britta Loutfi-Krauss; Laura Masi; Alan H. Mayville; Ante Mestrovic; Maaike
Milder; Alessio G. Morganti; Dirk Rades; Ulla Ramm; Claus Roedel; Frank-Andre Siebert; W. den Toom; Lei Wang; Stefan Wurster; Achim Schweikard; Scott G. Soltys; Samuel Ryu; Oliver Blanck. Treatment Planning for Spinal Radiosurgery: A Competitive Multi-Platform Bench Mark Challenge. Strahlenther Onkol.
Adrian Nalichowski, Isaac Kaufamn, John Gallo, Todd Bossenberger, Tim Solberg, Ezequiel Ramirez, Yulong Yan, Julie Fredrick, Tewfik Bichay, Alan Mayville and Jay Burmeister. Single Single fraction radiosurgery/stereotactic body radiation therapy (SBRT) for spine metastasis: A dosimetric comparison of multiple delivery platforms. J Appl Clin Med Phys 18:164-169, 2017.
Tewfik J. Bichay, Stewart Davis, Alan H. Mayville, and Nicolas D.T. Bichay. A quantitative assessment of imaging frequency on the treatment setup accuracy in TomoTherapy. Clinics in Oncology: Chemotherapy and Radiotherapy. 1:1-6 (1064), 2016.
Joey L. Meadows, Tewfik J. Bichay and Colin G. Orton. Low dose-rate brachytherapy for the treatment of cervix cancer is outdated and should be discontinued. Med. Phys. 43:4963-4965, 2016.
Bichay T J, Mayville A. The Continuous Assessment of Cranial Motion in Thermoplastic Masks During CyberKnife Radiosurgery for Trigeminal Neuralgia. Cureus 8:5 e607, 2016.
Tewfik Bichay, Sonja Dieterich and Colin Orton. Submillimeter accuracy in radiosurgery is not possible. Medical Physics 40:050601-1-4, 2013.
T J Bichay, C M Wilkinson and C Chen. TomoTherapy radiosurgery for trigeminal neuralgia:
a technical perspective. World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings 39:1891-1894, 2012.
T J Bichay and P. Ebrom. A quantitative analysis of the reliability of aquaplast mask immobilization for cranial radiosurgery with TomoTherapy. World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings 39:1915-1918, 2012.
Tewfik Bichay, Daliang Cao, and Colin G. Orton. Helical tomotherapy will ultimately replace linear accelerator based IMRT as the best way to deliver conformal radiotherapy. Medical Physics 35:1625-1628, 2008.
Tewfik Bichay, Chen Chen, James Kane, Steven Klafeta. TomoTherapy for Cranial Radiosurgery/Radiotherapy. World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings Volume 14, pp 1852-1855, 2007.
Tewfik Bichay, R. Rogow, J. Meadows and C. Chen. Dosimetric Characterization of a Compact Doorless High Energy Linear Accelerator Vault. World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings Volume 14, pp 1980-1983, 2007.
Gerig LH, Szanto J, Bichay TJ, and Genest P. A translating bed technique for total body irradiation. Phys. Med. Biol. 39:19-35, 1994.
Cygler J, Klassen NV, Ross CK, Bichay TJ, and Raaphorst GP. The survival of aerobic and anoxic human glioma and melanoma cells at ultrahigh and clinical doserates. Rad. Res. 140:79-84, 1994.
Raaphorst GP, Bussey A, Thakar M, Bichay TJ, and Ng CE. Postirradiation exposure to hypotonic saline shows normal damage processing in radiation-sensistive cell lines. Int. J. Radiat. Biol. 64:593-600, 1993.
Bichay TJ, Feeley MM, and Raaphorst GP. A comparison of heat sensitivity, radiosensitivity and PLDR in four human malignant melanoma cell lines. Melanoma Research 1:63-69, 1992.
Bichay TJ, Adams EG, Inch WR, Adams WJ, Brewer JE, and Bhuyan BK. HPLC and flow cytometric analyses of adriamycin and menogaril by mono layers and multicell spheroids. Selective Cancer Therapeutics 6:153-165, 1990.
Bichay TJ, and Inch WR. Resistance of V79 multicell spheroids to mitoxantrone: Drug uptake and cytotoxicity. Cancer Drug Delivery 4:201-211, 1987.
Bichay TJ, Best MW and Korpatnick DJ. Laboratory guide for the handling and disposal of radioactive isotopes. The London Regional Cancer Center, London, 1985, and revised 1987.
Bichay TJ. The intrinsic resistance of V79 multicell spheroids to mitoxantrone, adriamycin and menogaril. Ph.D. thesis, the University of Western Ontario, London, 1987.
Bichay TJ, and Roy RM. Modification of survival and hematopoiesis in mice by tocopherol injection following irradiation. Strahlentherapie und Onkologie 162:391-399, 1986.
Bichay TJ. Post-irradiation modification of survival and hematopoiesis by tocopherol. M.Sc. thesis, Concordia University, Montreal, 1983.
ABSTRACTS AND LETTERS
A Mayville and T Bichay. The continuous assessment of Cranial Motion in Thermoplastic Masks During CyberKnife Radiosurgery. Medical Physics44:6, 2845, 2017.
Bichay T, and Mayville, A. CyberKnife with MLC for Treatment of Large Volume Tumors: A Feasibility Study. Medical Physics 43:6, 3587, 2016.
Tewfik J Bichay, Chen Chen and Alan Mayville. Treatment Time Efficiency and Dosimetric Accuracy of a New CyberKnife Multileaf Collimator. International Stereotactic Radiosurgery Society (ISRS) Yokohama, Japan, June 7-11, 2015.
Kevin T. Jordan, Alan Mayville, and Tewfik Bichay. A Systematic Analysis of the Error Sources Within the CyberKnife M6 Daily QA Test. World Congress on Medical Physics and Boimedical Engineering, Toronto, Canada, June 7-12, 2016.
T Bichay, M Wilkinson, J Kokko, J Kane and G Padula. The Use of TomoTherapy for the Treatment of Trigeminal Neuralgia. 2014 Accuray / AERO users meeting:Frontiers of Image-Guidance. Minneapolis, MN, May 6-7, 2014.
T Bichay, S Dieterich and D Schlesinger, Accuracy and Precision in Cranial Radiosurgery. Medical Physics 40:6, 532, 2013.
O De Hertogh, Y Boukour, R Viard and T Bichay. The Weakest Link …. Medical Physicists Need Dedicated Software and Further Training for Rotational IMRT. Radiotherary and Oncology 106:1, S16, 2013.
O De Hertogh, TJ Bichay, R Viard, B Germain, Y Boukour, The Weakest Link-Medical Physicists Need Dedicated Software And Further Training To Improve The Quality Of Rotational IMRT. Int J Radiat Oncol Biol Phys 84:3, S130-131, 2012.
Tewfik J. Bichay and Chen Chen, TomoTherapy Treatment Couch Velocity Verification Using TomoDose. Medical Physics 39:6, 3743, 2012.
T J Bichay, C M Wilkinson and C Chen. TomoTherapy radiosurgery for trigeminal neuralgia: a technical perspective. World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings 39:18911894, 2012.
T J Bichay and P. Ebrom. A quantitative analysis of the reliability of aquaplast mask immobilization for cranial radiosurgery with TomoTherapy. World Congress on Medical Physics and Biomedical Engineering, IFMBE Proceedings 39:1915-1918, 2012.
T Bichay, J Kane, P Ebrom, C Chen, Analysis of a Non-Invasive Patient Mask Immobilization System for Cranial SRS With TomoTherapy. Medical Physics 38:6, 3616, 2011.
T Bichay, J Meadows, C Chen and N Klynstra,, A quantitative assessment of the improvement in lung treatment setup accuracy with IGRT in TomoTherapy. Medical Physics 37:6, 3152-3153, 2010
T Bichay and D Schippers, Characterizing the Scattered Radiation from a C-arm Fluoroscope. Medical Physics 37:6, 3359, 2010.
T Bichay and C Chen, The Use of TomoDose for TomoTherapy MLC Alignment Verification. Medical Physics 36:6, 2591, 2009.
T Bichay, C Chen, J Meadows, D Schippers, D Lucas, K Ruchala, E Chao, Dosimetric and Image Quality Analysis of a New Ultrafine Imaging Mode in TomoTherapy. Medical Physics 35:6, 2696, 2008.
E Chao, T Bichay, D Lucas, K Ruchala, G Olivera, Longitudinal resolution of the TomoTherapy® MVCT image and potential improvements. Medical Physics 35:6, 2706, 2008.
J Meadows, M Wilkinson , T Bichay, 4D-CT What Is It Good For? Medical Physics 35:6, 2835, 2008.
C Chen, K Trierweiler, T Bichay, Comparison of shifts in CBCT and Tomotherapy imaging modalities in prostate IGRT. Medical Physics 35:6, 2691-2, 2008.
T Bichay, J Meadows, H Tran, A Nash, C Chen. A quantitative assessment of the improvement in treatment setup accuracy with IGRT in TomoTherapy. Medical Physics 34:2380, 2007.
C Chen, J Meadows, T Bichay, Improvement in IMRT dose calculation accuracy with megavoltage CT imaging in the presence of high Z materials. Medical Physics 34:6, 2459, 2007.
J Meadows, T Bichay, C Chen, D Schippers. Inter-Observer Image Quality Analysis of Megavoltage Cone BeamCT versus Megavoltage Fan Beam-CT. Medical Physics 34:6, 2382, 2007.
Tewfik Bichay, Chen Chen, Stewart Davis, James Kane, Steven Klafeta, Joe Meadows.
TomoTherapy for Cranial Radiosurgery/Radiotherapy. Proceedings of The World Congress On Medical Physics and Engineering, Springer, pp 1737, 2006.
Tewfik Bichay, R. Rogow, J. Meadows and C. Chen. Dosimetric Characterization of a Compact Doorless High Energy Linear Accelerator Vault. Proceedings of The World Congress On Medical Physics and Engineering, Springer, pp 1864, 2006.
C Chen, J Meadows and T Bichay. TomoDose: A Daily Quality Assurance Device for Helical TomoTherapy. Medical Physics 33:6, 2207, 2006.
Tewfik J. Bichay, Kane, James M., Klafeta, Steve, Chen, Chen. Cranially-Implanted gold fiducials for stereotactic radiotherapy with TomoTherapy. Radiological Society of North America (RSNA) pp 284, 2005.
Tewfik J. Bichay. Doorless bunker for radiotherapy. Trinity-Health Fall Conference, pp. 79, November 7-8, 2005.
Sharma, R., Artebery, V.E., Carethers, J., Bichay, T.J., Chen, C.,Porter, A.T. 3D Conformal breast irradiation versus IMRT utilizing sequential tomotherapy, step and shoot and helical tomotherapy. Int J Radiat Oncol Biol Phys 63: S255, 2005.
Tewfik J. Bichay, Chen Chen, Joey Meadows. A shielding design for a high-energy doorless vault. Medical Physics 32:6, 1990, 2005.
Chun, P. , Padula, G. D., Rahbar, M. H., He, J., Bichay, T., Wilkinson, C. M., Kane J. M. Normalization of prostate specific antigen (PSA) in patients treated with intensity modulated radiotherapy (IMRT) for clinically localized prostate cancer. Journal of Clinical Oncology 16s:445s, 2005
Tewfik J. Bichay, Edward R. Lawrence and Alex A. Kania. Inverse Planning System-Generated Fluence Maps as a Tool for IMRT Treatment Commissioning and Quality Assurance. Medical Physics 29:6, 1923, 2002.
Raaphorst GP, Ng CE, and Bichay T J. Further on prediction of radiotherapy response using SF2, is it methodology or mythology? Radiation Oncology 31:88-89,1994.
Aref I, Cross P, Bichay T, and Nair B. Lung cancer after radiation therapy for breast cancer. Cancer 72:33683369,1993.
Cygler C, Bichay T J, Caloia D, Raaphorst GP, Klassen NV and Ross CK. The effect of doserate and hypoxia on the radiation response of human malignant glioma cells. Presented at the 40th Annual Meeting of the Radiation Research Society, Salt Lake City, Utah, USA, March 1992.
Bichay TJ, Feeley MM, and Raaphorst GP. Recovery of melanoma cells, and polymerase activity, after heat damage. Proceedings of the 9th International Congress of Radiation Research 1:374, 1991.
Raaphorst GP, Zakhour E, Danjoux CE, Gerig LH, and Bichay T J. Hyperthermia: Biological rational and analysis of clinical data. Thirteenth Clinical Cancer Research Conference. Lake Couchiching, Ontario, Canada, October 1991.
Raaphorst GP, Bichay T J, and Feeley MM. Radiation response and thermal sensitization in human tumor cells demonstrating radioresistance. Proc. Radioresistance of Human Tumor Cells. McGill University, 1991.
Bichay T J, Feeley MM, Heller DP, and Raaphorst GP. Radiation and heat sensitivity of human melanoma cells: Relationship to and polymerase. Presented at the 38th Annual Meeting of the Radiation Research Society, New Orleans, Louisiana, USA, April 7-13, 1990.
Bichay T J, Werner MM, Cecil MD, Morrison DP, and Gentner NE. Radiosensitivity of stimulated peripheral blood lymphocytes isolated from normal individuals and from cancer patients. Presented at the 37th Annual Meeting of the Radiation Research Society, Seattle, Washington, USA, March 18-23, 1989.
Bichay T J, Werner MM, Gentner NE, and Morrison DP. A rapid test for radiation sensitivity using peripheral blood lymphocytes. The 14th L.H. Gray Conference, New College, Oxford, England, September 11-15, 1988.
Bichay T J, Adams EG, Inch WR, and Bhuyan BK. Uptake and cytotoxicity of doxorubicin and menogaril in V79 monolayers and multicell spheroids. The 11th Clinical Cancer Research Conference, Lake Couchiching, Geneva Park, Canada, September 28-30, 1987.
Bichay T J, Inch WR, Adams EG, Brewer JE, Adams WJ, and Bhuyan BK. The accumulation and toxicity of anthracyclines in multicell spheroids and in monolayers. The 3rd International Conference on Spheroids in Cancer Research, Cambridge, England, July 1987.
Bichay T J, and Inch WR. Intrinsic resistance of multicell spheroids to mitoxantrone is not solely due to restricted drug penetration. Conference on The Prediction of Tumor Treatment Response, Banff, Alberta, Canada, April 21-24, 1987.
Bichay T J, Adams EG, Inch WR, Adams WJ, Brewer JE, and Bhuyan BK. Comparative uptake of menogaril and adriamycin in V79 monolayers and spheroids measured by HPLC and by flow cytometry. The Cell Kinetics Society, Vancouver, Canada, March 25-28, 1987.
Bichay T J, Adams EG, Inch WR, Adams WJ, Brewer JE, and Bhuyan BK. Uptake and cytotoxicity of doxorubicin and menogaril in V79 monolayers and multicell spheroids. Proceedings of the American Association for Cancer Research 2:263, 1987.
Badiner G, Bichay T J, and Bhuyan BK. Menogaril resistance results in amplified m.Qr1 gene in Chinese hamster V79 cells but not in mouse leukemia p388 cells. Proceedings of the American Association for Cancer Research 2:281 , 1987.
Bichay T J, and Inch WR. Resistance of multicell spheroids to adriamycin, mitoxantrone and menogaril. Proceedings of the 14th International Cancer Congress 1:164, 1986.
Bichay T J, and Inch WR. Altered anthracycline uptake and toxicity by a calcium channel blocker. The 29th Annual Meeting of the Canadian Federation of Biological Societies, June 16-20, Guelph, Canada. Abstract #PO57, pp. 147,1986.
Bichay T J, and Inch WR. The effect of verapamil on the cytotoxicity of adriamycin, mitoxantrone, and menogaril. Proceedings of the American Association for Cancer Research 27:384, 1986.
Bichay T J, and Inch WR. Resistance of multicell spheroids to anthracyclines. Proceedings of the American Association for Cancer Research 2:392, 1986.
Bichay T J, and Inch WR. The in vitro cytotoxicity of mitoxantrone to V79 cells grown as mono layers and as multicell spheroids. The 10th Clinical Cancer Congress, Lake Couchiching, Geneva Park, Canada. September 300ctober 2, 1985.
Bichay T J, and Inch WR. The in vitro cytotoxicity of mitoxantrone to V79 cells grown as monolayers and as multicell spheroids. Proceedings of the American Association for Cancer Research 26:354, 1985.
________________________ July 27, 2018
Tewfik Bichay, Phd, ABMP
Anna Wrona, MD PhD,
Department of Oncology and Radiotherapy, Medical University of Gdansk
Consultant of radiation oncology and academic in one of the most exhilarating Polish cancer centers – in the Department of Oncology and Radiotherapy of Medical University of Gdańsk.
- European Thoracic Oncology Platform(ETOP)
- European Organization for Research and Treatment of Cancer(EORTC).
- Polish Society of Oncology (PTO),
- European Society for Radiotherapy and Oncology(ESTRO)
- International Association for the Study of Lung Cancer (IASLC).
- Associate editor of Journal Club column in Nowotwory Journal.
Area of interest:
- Thoracic oncology.
- Cancer molecular biology and resistance mechanisms.
- ESMO 2017.
- Polish Congress of Medical Oncology
- Conference of Polish Lung Cancer Group
- World Conference on Lung Cancer.
Current Positions and Titles
Chairman of Kasr Al-Ainy School Of Oncology (KASO), official Cancer education organization, Department of Oncology, Faculty of Medicine, Cairo University. Professor of Clinical Oncology, Faculty of Medicine, Cairo University, Cairo, Egypt President of Africa Middle East Cancer Research Inter group. Referee for the Annals of Oncology Journal, THE BREAST, The Breast Journal (TBJ), BMC Cancer, Chemotherapy journal , Advances in Cancer Research & Treatment , Journal of the Egyptian National Cancer Institute, and the Chinese Clinical Oncology Journal. Pioneering Activity
Past chairman of the Oncology Department, Faculty of Medicine, Cairo University. First to represent the Middle East countries on the ASCO international committee, for a period of 5 years ( May 1997-May 2002) Chief editor of 2 educational books ASCO PANARAB Lymphoma Conference (1999) and the MD Anderson Cancer Centre / Cairo University joint meeting (2006) More than 80 scientific and research publications. Scientist of the Year from the International Biographical Centre, Cambridge, UK (2002) The Order of Merit,Cambridge University (2002) The Best Arab Oncologist from the Lebanese Society of Medical Oncology (LSMO,2004) The recognition award for significant contribution to the Oncology field in the middle east from UAE (Dubai -2013) Dr Azim signed the Charter of Paris against Cancer on behalf of the Arab World in February 2000.
Martine J. Piccart, MD, PhD, is Professor of Oncology at the Université Libre de Bruxelles (ULB)
and Director of Medicine at the Jules Bordet Institute, in Brussels, Belgium. Earning her medical degrees at the ULB and oncology qualifications in New York and London, she is also member of the Belgian Royal Academy of Medicine.
With a primary interest in breast cancer and drug development, Dr. Piccart is a leader in international research collaboration and is the principal or co-principal investigator of many clinical trials, including HERA, MINDACT and ALTTO. She is co-founder and Chair of the Breast International Group (BIG), uniting 49 academic research groups from around the world and running over 30 trials under its umbrella. BIG’s research programmes include the European Commission supported TRANSBIG consortium of 28 institutions in 11 countries (running with the EORTC the MINDACT trial) and NeoBIG, an innovative biomarker and drug development programme focused on neo-adjuvant trials.
Dr. Piccart was President of ESMO (2012-2013) and ECCO (2014-2015). She is a member of the ESMO Magnitude of Clinical Benefit Scale Working Group and active in numerous professional organisations. She is a former president of EORTC and served on the ASCO Board.
(Co) author of more than 390 publications in peer-reviewed journals, she has received numerous prestigious awards for her research contributions including the Jill Rose Award (New York), the William L. McGuire Award (San Antonio) and, recently, the Umberto Veronesi Award for the Future Fight against Cancer (Cancun).
Dr Alberto Bossi is currently Head of the Urology and Prostate Brachytherapy Unit at the Gustave Roussy Cancer Institute in Villejuif, France. His professional career started in Italy where he was born: he graduated in Medicine and Surgery in 1988 and specialized in Radiotherapy and Diagnostic Radiology in 1992 at the University of Pavia. After a Clinical Fellowship at the Dept of Radiation Oncology at the Academic Medical Centre in Amsterdam he worked in Como and Milan. In 2001 he was appointed Adjunct Clinical Head at the Department of Radiation Oncology of the University Hospital in Leuven, Belgium where he worked till 2006 before moving to IGR.Dr Bossi is member of several scientific societies, including ESTRO, ASTRO, EAU. He has served as Coordinator of the Genito-Urinary Working Group of the EORTC in 2006. He is the Course Director of the Multidisciplinary ESTRO-EAU-ESMO Teaching Course on Prostate Cancer and teacher at both the ESO (European School of Oncology) and EAU (European Association of Urology) Prostate Courses. He is PI and co-PI (Principal Investigator) of two major European Phase III trials on Prostate Cancer and has published over 40 papers in peer-reviewed journals. Dr Bossi is reviewer for several journals including the IJROBP, European Urology, Radiotherapy and Oncology, Annals of Oncology.
Dr. Bouthaina Dabaja received her Medical Doctorate at the Lebanese University. She completed her clinical residencies at the American University of Beirut and The University of Texas MD Anderson Cancer Center. She began her career at MD Anderson following her residency in 2006 and has progressed from Assistant Professor to Professor and Section Chief of the Hematology Section in Radiation Oncology. Her primary clinical goal is patient care with an emphasis on maintaining and improving cure rate in patients with lymphoma while decreasing the short and long term side effects of treatment. She is extensively involved in clinical trials to investigate multiple strategies to deliver better treatment options for lymphoma patients with the goal of minimizing long term side effects on patients treated for mediastinal lymphomas which remains a great clinical challenge.
Associate Professor, Department of Radiation Oncology,
ESMO Board MemberDirk Arnold is Director of the Dept. Medical Oncology at Klinik für Tumorbiologie, Freiburg, Germany. Before taking this position, he was 2010 appointed as Director of the University Cancer Centre in Hamburg (UCCH) and held positions at the University Departments for Oncology and Haematology in Halle-Wittenberg and Berlin. His major field of scientific interest are gastrointestinal cancers, and here specifically modern therapeutic approaches in biomarker-driven decision processes, and multimodal treatment strategies, also including other specialities. Here, he serves as chairman of Colorectal Cancer Study Group of the German AIO, a major collaborative group in clinical oncology. Within the AIO framework, he served as founding member of the Central Clinical Trials Office, underlining his expertise also in methodology of clinical research. Furthermore, his interest is the organisation of larger collaborative research structures and of integrated cancer centre networks. Prof. Arnold is also member of the American Society of Clinical Oncology and Task Force Member of the National Cancer Institute, as well as Board member of the EORTC GI study group. Furthermore, he is board member of the German Society of Haematology and Medical Oncology (DGHO), and member of the German Cancer Society. Within ESMO, since 2012 he is section editor for GI cancers in the Guidelines Committee and Associate Editor with .
Consultant of Clinical Radiotherapy and Assistant Professor